Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Association of mature ERBB2 with HSP90 chaperone and its co-chaperone CDC37

Class:IdReaction:1227971
_displayNameAssociation of mature ERBB2 with HSP90 chaperone and its co-chaperone CDC37
_doReleaseFALSE
_timestamp2024-03-20 23:45:50
compartment[Compartment:70101] cytosol
[Compartment:876] plasma membrane
created[InstanceEdit:1227968] Orlic-Milacic, Marija, 2011-03-14
input[Complex:1225828] CDC37 [cytosol] [Homo sapiens]
[EntityWithAccessionedSequence:372889] ERBB2 [plasma membrane] [Homo sapiens]
[Complex:1221657] HSP90 [cytosol] [Homo sapiens]
[EntityWithAccessionedSequence:1358718] ERBIN [plasma membrane] [Homo sapiens]
isChimericFALSE
literatureReference[LiteratureReference:1227977] Sensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90
[LiteratureReference:1227978] Surface charge and hydrophobicity determine ErbB2 binding to the Hsp90 chaperone complex
[LiteratureReference:1358720] ERBIN: a basolateral PDZ protein that interacts with the mammalian ERBB2/HER2 receptor
modified[InstanceEdit:1227985] Orlic-Milacic, Marija, 2011-03-15
[InstanceEdit:1247492] Orlic-Milacic, Marija, 2011-04-01
[InstanceEdit:2267358] Orlic-Milacic, M, 2012-05-24
[InstanceEdit:8879177] Wu, G, 2016-07-15
[InstanceEdit:9634291] Orlic-Milacic, Marija, 2019-01-09
[InstanceEdit:9866055] Orlic-Milacic, Marija, 2024-03-20
nameAssociation of mature ERBB2 with HSP90 chaperone and its co-chaperone CDC37
ERBB2 + HSP90 homodimer + CDC37 homodimer => ERBB2:HSP90:CDC37
negativePrecedingEvent[NegativePrecedingEvent:9866018] Futile Cycle: ERBB2 forms heterodimers with ligand-activated ERBB receptors: EGFR, ERBB3 and ERBB4
[NegativePrecedingEvent:9866009] Futile Cycle: ERBB2 homodimerization
output[Complex:1227970] ERBB2:ERBIN:HSP90:CDC37 [plasma membrane] [Homo sapiens]
species[Species:48887] Homo sapiens
stableIdentifier[StableIdentifier:8914087] R-HSA-1227971.1
summation[Summation:1227969] Mature ERBB2 requires continual association with HSP90 and C...
(hasEvent)[Pathway:1227986] Signaling by ERBB2 [Homo sapiens]
(precedingEvent)[Reaction:1227964] ERBB2 homodimerization [Homo sapiens]
[Reaction:1918092] CHIP (STUB1) mediates ubiquitination of ERBB2 [Homo sapiens]
[Reaction:1918095] CUL5 mediates ubiquitination of ERBB2 [Homo sapiens]
[Reaction:1963589] ERBB2 forms heterodimers with ligand-activated ERBB receptors: EGFR, ERBB3 and ERBB4 [Homo sapiens]
[Reaction:9652264] ERBB2 binds TKIs [Homo sapiens]
[Reaction:9652277] ERBB2 binds trastuzumab [Homo sapiens]
[Reaction:9665726] ERBB2 binds pertuzumab [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by Association of mature ERBB2 with HSP90 chaperone and its co-chaperone CDC37 (1227971)